ArticleInternational journal of hematology2022

Higher incidence of thrombocytopenia during obinutuzumab plus bendamustine therapy for untreated follicular lymphoma: a retrospective analysis by the Okayama Hematology Study Group.

Yuki Fujiwara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.